RE: New contract24 Jul 2021 21:59
Hi David,
AgentB also mentioned a similar paradox investing wise regarding AVCT.
I honestly can’t advise. All I can say is in the case of AVCT if they land a substantial LFT contract(s) it will be possible to value the company more appropriately. They have just listed AV6000 on the clinical trial site but it (obviously) has a 2023 end date.
I held AVCT from 30p sold at 200p bought a nearly new decent car, got lambasted on the website for saying AVCT was then over valued and needed cash and then bought back at sub 100p after their raise! For clarity though I did also add on the CE RNS recently at like 280 as I thought at last! But sold as they dropped below support and have recently bought back at a 130 average but far fewer shares. Their mcap now is more representative but it could explode on the right news!
As for SNG, it’s been an unbelievable ride!
I really don’t want to bore this excellent BB but I will just say it’s been a rare share that keeps on giving. I took over 5 bags out and am now buying again. Risk money, like a do or die drill, for H2 and I will derisk as the SP hopefully ascends. Then in the same space there is DDDD I took out 4 bags and no longer hold! I have others and my fair share of losers!
Anyways, I hope that shows you what sort of investor I am. I have nothing to hide. Peeps may say I am a trader. Well we all trade, it’s just the time between buying and selling that seems to differentiate a trader from an investor. What is that exact cut off? Lol! and of course frequency. Sorry I get bored by so many Warren Buffet quotes. He wouldn’t even invest here! Lol!
So ONC. Well, you will unlikely see fireworks here because the market does not understand it. We do not have a divi metric or even anything like approaching that. The normal ROCE, ROI, NPV or for that matter even EBITDA metrics can become obsolete in a blink because the growth is so rapid.
So the question is how do we value a company that the market cannot.
One can be harsh on oneself by saying I got it wrong because I bought some shares at 220 and 200p, You see after the 180 placing and subsequent climb I thought the pull back to 200 was it!
Anyways I bought so many more on the dip like IPhone that my average is also now up significantly to 181. So I don’t have the answers but what I do have from my investing experience and conviction is that IMVHO ONC is one of the most promising low risk, high growth, British biotechs out there with one of the best management teams you will find.
Growing. Doing deals. USP. Worldwide presence. Cash favourable. Experienced and capable BoD. Niche market, moat. Contracts with majors. Govt grants. Evidence based databank. Recurring revenues. In no particular order I could go on!
That gives me reason to invest at below my £4 conservative valuation in less than 2 years.
Trek